Studies have shown that the neuregulin 1 (NRG1) and human epidermal growth factor (EGF) receptor (HER) signaling pathway promotes carcinogenesis and the pathogenesis of multiple human cancers, including breast cancer (BC) [4–7]. This evidence concerns the gene NRG1 and breast cancer.